ACM Global Central Lab's Acquisition Expands Asia-Pac Presence
ACM Global Central Lab announced it has acquired Phoenix Pharma Central Services
ACM Global Central Lab announced it has acquired Phoenix Pharma Central Services (S) Pte. Ltd (Phoenix PCS), a central laboratory services provider for clinical trials in the Asia-Pacific region, by adding two clinical trial laboratory locations in Singapore and Shanghai, China. The addition of these laboratories, comes on the heels of last year’s expansion and relocation of its ACM York facilities.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
